Intel Slides 6.6% — Street Stays Split as Options Calm Returns

Intel enters the back half of August under renewed price pressure, closing Tuesday at $96.69 — down 6.6% on the day — yet with the broader positioning picture looking less alarmed than the price action suggests.

The options market is the place to start, because the defensive surge flagged in last Tuesday's trader note has visibly unwound. The put/call ratio has eased to 0.99, barely a half standard deviation above its 20-day average of 0.98. That is a meaningful reversal from the 2.6 standard-deviation spike recorded on August 12, when the ratio hit 1.03 in the immediate wake of the $20 billion equity offering. Options traders were hedging hard into the dilution shock; they are no longer. The ratio is now close to the middle of its 52-week range, with the annual peak at 1.16 and the low at 0.61. Defensive positioning has normalised even as the stock dropped another leg.

Short interest tells a similarly calm story. Bears have not used Tuesday's selloff as a re-entry point — at least not yet. Short interest edged up just 0.8% on the day to 119 million shares, equivalent to 2.5% of free float. That is still the lightest short load in at least three months, down roughly 5% from a month ago when it was tracking above 125 million shares. The borrow market reflects zero stress: availability is effectively uncapped, with billions of shares available for lending and cost-to-borrow at 0.47% — up 40% on the week in percentage-change terms, but rising from an already negligible base. There is no squeeze dynamic in play here.

The Street's positioning is more nuanced, and the divergence is real. The consensus sits at "buy," but the analyst community is anything but unified. Morgan Stanley's Joseph Moore raised his target to $84 after the July 24 print — still nearly 13% below the current price. JPMorgan's Harlan Sur, maintaining Underweight, lifted his target from $45 to $85, a significant revision that still implies downside from here. On the bullish end, B of A Securities holds a $160 target with a Buy rating, nearly 65% above Tuesday's close. The mean target across the analyst group is $115, which implies meaningful upside — but the spread between the $84 floor and $160 ceiling reflects genuine disagreement about which Intel is emerging from the foundry transformation. UBS trimmed its target to $112 from $121 on August 12, keeping Neutral. Baird moved the opposite direction, lifting to $125 from $75 while staying Neutral. The PE has contracted sharply, down 14 points over the past month to 55.6x, as the stock pulled back from its June highs. EV/EBITDA is at 20.6x, down 3 points over the same window.

The CEO trade logged last week remains the most concrete anchor in the bull case. Lip-Bu Tan's $10 million open-market purchase at $95 on August 11 — right into the dilution pressure — now looks prescient in price terms, since the stock briefly recovered above $100 before Tuesday's reversal. The net insider position over 90 days is a positive $15.8 million. Institutional holders are broadly stable: BlackRock added 6.4 million shares in the most recent period, Capital Research added 10.2 million, and FMR added 34.7 million. The top-five holders collectively hold more than 30% of outstanding shares, providing a stable base even as the offering expanded the float.

The pattern from recent earnings is worth keeping in mind. The July 24 print produced a single-day drop of 8.5% and a five-day loss of 10%. That follows a prior print which also produced a double-digit five-day decline. Intel has delivered a consistent post-earnings pattern of selling — even when numbers beat. The next event is October 22. Tuesday's 6.6% decline, in the absence of any fresh fundamental catalyst, is the kind of move that typically triggers fresh analyst commentary and position reassessment in the days that follow — and whether that arrives with upgraded or downgraded targets will be the first signal of how the Street reads the post-offering setup heading into Q3 results. Peer action on Tuesday was broadly negative: AMD fell 4.3%, LRCX dropped 4.6%, and GFS declined 6.6%, suggesting sector-wide pressure rather than Intel-specific selling — though that framing will be tested if the stock fails to reclaim $100 in the sessions ahead.